Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal fluticasone via OptiNose device in adult bilateral nasal polyposis
2006-006340-60Phase 2Terminated
- Sponsor
- OptiNose
- Start
- Jan 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic rhinosinusitis with nasal polyps (CRSwNP) comparing Fluticasone propionate with Placebo (2 arms). Primary endpoint: Change in bilateral polyp size. Started Jan 2007; status: terminated.
02
Drugs
fluticasone propionate
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on 2006-006340-60.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006340-60.